STOCK TITAN

Nuvalent (NUVL) CEO trades 30K shares after option exercises

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Nuvalent, Inc. President and CEO James Richard Porter reported an exercise-and-sell transaction involving company stock. He exercised stock options covering 13,714 shares of Class A Common Stock at an exercise price of $18.93 per share and 16,286 shares at $27.85 per share, acquiring 30,000 shares in total. On the same date, he sold 30,000 shares of Class A Common Stock in open-market transactions at prices reported as $103.21, $103.78, $104.78 and $105.60 per share. According to a footnote, these sales were made pursuant to a Rule 10b5-1 trading plan adopted on December 4, 2025. Following the transactions, he directly held 324,879 shares of Nuvalent Class A Common Stock.

Positive

  • None.

Negative

  • None.
Insider Porter James Richard
Role President and CEO
Sold 30,000 shs ($3.11M)
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 13,714 $0.00 --
Exercise Stock Option (Right to Buy) 16,286 $0.00 --
Exercise Class A Common Stock 13,714 $18.93 $260K
Exercise Class A Common Stock 16,286 $27.85 $454K
Sale Class A Common Stock 11,354 $103.21 $1.17M
Sale Class A Common Stock 12,425 $103.78 $1.29M
Sale Class A Common Stock 6,121 $104.78 $641K
Sale Class A Common Stock 100 $105.60 $11K
Holdings After Transaction: Stock Option (Right to Buy) — 208,686 shares (Direct); Class A Common Stock — 338,593 shares (Direct)
Footnotes (1)
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.52 to $103.51, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) of this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.52 to $104.51, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.52 to $105.48, inclusive. The shares underlying this option are fully vested. The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
Options exercised at $18.93 13,714 shares Stock options exercised at $18.93 per share into Class A Common Stock
Options exercised at $27.85 16,286 shares Stock options exercised at $27.85 per share into Class A Common Stock
Total shares from option exercises 30,000 shares Combined underlying shares from both stock option exercises
Shares sold at $103.21 11,354 shares Open-market sale at a weighted average price of $103.21 per share
Shares sold at $103.78 12,425 shares Open-market sale at a weighted average price of $103.78 per share
Shares sold at $104.78 6,121 shares Open-market sale at a weighted average price of $104.78 per share
Shares sold at $105.60 100 shares Open-market sale at a price of $105.60 per share
Post-transaction direct holdings 324,879 shares Directly held Nuvalent Class A Common Stock after all reported transactions
Rule 10b5-1 trading plan financial
"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Option (Right to Buy financial
"security_title: Stock Option (Right to Buy)"
weighted average price financial
"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.52 to $103.51, inclusive."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Class A Common Stock financial
"underlying_security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
Sale in open market or private transaction financial
"transaction_code_description: Sale in open market or private transaction"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Porter James Richard

(Last)(First)(Middle)
C/O NUVALENT, INC.
ONE BROADWAY, 14TH FLOOR

(Street)
CAMBRIDGE MASSACHUSETTS 02142

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Nuvalent, Inc. [ NUVL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/06/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock04/06/2026M(1)13,714A$18.93338,593D
Class A Common Stock04/06/2026M(1)16,286A$27.85354,879D
Class A Common Stock04/06/2026S(1)11,354D$103.21(2)343,525D
Class A Common Stock04/06/2026S(1)12,425D$103.78(3)331,100D
Class A Common Stock04/06/2026S(1)6,121D$104.78(4)324,979D
Class A Common Stock04/06/2026S(1)100D$105.6324,879D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$18.9304/06/2026M(1)13,714 (5)01/04/2032Class A Common Stock13,714$0.00208,686D
Stock Option (Right to Buy)$27.8504/06/2026M(1)16,286 (6)01/06/2033Class A Common Stock16,286$0.00131,494D
Explanation of Responses:
1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2025.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.52 to $103.51, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) of this Form 4.
3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.52 to $104.51, inclusive.
4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.52 to $105.48, inclusive.
5. The shares underlying this option are fully vested.
6. The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
/s/ Nathan McConarty, attorney-in-fact04/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Nuvalent (NUVL) CEO James Richard Porter report?

Nuvalent CEO James Richard Porter exercised options for 30,000 shares and sold 30,000 shares of Class A Common Stock. The filing shows option exercises followed by open-market sales, leaving him with 324,879 directly held shares after the transactions.

How many Nuvalent (NUVL) shares did the CEO sell in this Form 4 filing?

The CEO sold 30,000 shares of Nuvalent Class A Common Stock. These were executed in four open-market sale transactions with reported prices of $103.21, $103.78, $104.78 and $105.60 per share, as disclosed in the Form 4 filing.

What stock options did the Nuvalent (NUVL) CEO exercise in this transaction?

He exercised stock options covering 13,714 shares at an exercise price of $18.93 per share and 16,286 shares at $27.85 per share. Both option exercises converted into Class A Common Stock on the same transaction date, totaling 30,000 underlying shares.

Was the Nuvalent (NUVL) CEO’s share sale under a Rule 10b5-1 plan?

Yes. A footnote states the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 4, 2025. Such plans prearrange trading activity, indicating the timing of these sales was set in advance rather than decided spontaneously.

How many Nuvalent (NUVL) shares does the CEO hold after this Form 4?

After completing the reported option exercises and sales, the CEO directly holds 324,879 shares of Nuvalent Class A Common Stock. This post-transaction holding figure is taken directly from the Form 4’s non-derivative holdings table.

What price information is given for the Nuvalent (NUVL) CEO share sales?

The Form 4 reports weighted average sale prices of $103.21, $103.78, $104.78 and $105.60 per share. Footnotes explain these are averages over multiple trades within narrower price ranges, and detailed trade-by-trade data is available upon request.